Biotech

All Articles

Roivant unveils brand-new 'vant' to progress Bayer high blood pressure med

.Matt Gline is back along with a brand new 'vant' firm, after the Roivant Sciences chief executive o...

Viridian eye health condition stage 3 hits, accelerating press to competing Amgen

.Viridian Therapies' period 3 thyroid eye condition (TED) professional test has attacked its own pri...

Bain introduces $3B fund permanently science business

.Along with a powerful record for recognizing rough diamonds, Bain Resources Lifespan Sciences (BCLS...

Genentech's cancer cells restructure created 'for medical causes'

.The latest selection to merge Genentech's 2 cancer cells teams was actually made for "clinical reas...

Tern oral GLP-1 reveals 5% fat loss at 1 month at highest dosage

.Terns Pharmaceuticals' decision to fall its liver disease passions may yet pay, after the biotech u...

Merck, Daiichi repeat early excellence in tiny mobile lung cancer cells with upgraded ADC information

.Merck &amp Co.'s long-running initiative to land a blow on small cell lung cancer (SCLC) has actual...

Boehringer, Bayer advance lung cancer medicines towards Astra war

.Some patients along with non-small cell bronchi cancer (NSCLC) have anomalies in a genetics referre...

MBX aims for $136M IPO to take opponent to Ascendis in to period 3

.MBX has fleshed out strategies to consume over $136 million from its IPO as the biotech tries to br...

Relay bosom cancer data tee up clash with AstraZeneca's Truqap

.Relay Rehabs has beaten its survival goal in a first-in-human breast cancer cells study, installing...

AZ summarizes AI-enabled TROP2 biomarker technique for Daiichi ADC

.AstraZeneca has actually made use of artificial intelligence to design a special biomarker for its ...